These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20375873)

  • 1. Treating uveitis in the developing world setting.
    Rathinam SR
    Int Ophthalmol Clin; 2010; 50(2):219-28. PubMed ID: 20375873
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of uveitis].
    Martenet AC
    J Fr Ophtalmol; 1979 May; 2(5):369-77. PubMed ID: 489906
    [No Abstract]   [Full Text] [Related]  

  • 3. The first edition of Ocular Immunologyand Inflammation for 2012.
    Zierhut M
    Ocul Immunol Inflamm; 2012 Feb; 20(1):1. PubMed ID: 22324893
    [No Abstract]   [Full Text] [Related]  

  • 4. [Options and strategy for the treatment of chronic endogenous uveitis].
    Garweg JG
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):367-72. PubMed ID: 17458817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating acute onset of psoriasis.
    Christopher GF; Meires J
    Nurse Pract; 2008 Jul; 33(7):7-10. PubMed ID: 18600164
    [No Abstract]   [Full Text] [Related]  

  • 6. A clinical approach to the medical treatment of uveitis.
    Luntz MH
    Adv Ophthalmol; 1978; 36():187-96. PubMed ID: 665406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and emerging treatments for patients with uveitis.
    Haupert CL; Jaffe GJ
    Int Ophthalmol Clin; 2000; 40(2):205-20. PubMed ID: 10791266
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ophthalmologic manifestations of sarcoidosis].
    Badelon I; Chaine G
    Ann Med Interne (Paris); 2001 Mar; 152(2):108-12. PubMed ID: 11357047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Traumatic uveitis: the problem of pathogenetic therapy].
    Valeeva RG; Grishina VS; Petrova TKh; Iluridze SL
    Vestn Oftalmol; 1998; 114(2):53-6. PubMed ID: 9621827
    [No Abstract]   [Full Text] [Related]  

  • 10. Crohn's disease. Achieving optimum health status.
    Plante ML
    Adv Nurse Pract; 2004 May; 12(5):28-35; quiz 35-6. PubMed ID: 15150912
    [No Abstract]   [Full Text] [Related]  

  • 11. Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet's uveitis.
    Lee RW; Dick AD
    Br J Ophthalmol; 2010 Mar; 94(3):269-70. PubMed ID: 20215370
    [No Abstract]   [Full Text] [Related]  

  • 12. [Uveitis: From diagnosis to treatment].
    Saadoun D; Trad S; Bielfeld P; Sene D; Abad S; Kaplanski G; Terrada C; Kodjikian L; Bodaghi B; Seve P
    Rev Med Interne; 2018 Sep; 39(9):673-675. PubMed ID: 29602609
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric uveitis.
    Sauberan DP
    Int Ophthalmol Clin; 2010; 50(4):73-85. PubMed ID: 20930582
    [No Abstract]   [Full Text] [Related]  

  • 14. Current aspects of uveitis. Nonspecific treatment.
    Schlaegel TF; O'Connor GR
    Int Ophthalmol Clin; 1977; 17(3):43-63. PubMed ID: 197041
    [No Abstract]   [Full Text] [Related]  

  • 15. TNFalpha-blocking agents or conventional immunosuppressive drugs in the therapy of children with uveitis? - an evidence based approach.
    Winterhalter S; Niehues T
    Klin Padiatr; 2008; 220(6):342-7. PubMed ID: 18949668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the course and therapy of the immunological and the nonspecific iridocyclitis in rabbits.
    Giełdanowski J; Szary A
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):739-42. PubMed ID: 571269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Uveitis in the Developing World". Preface.
    Arevalo JF; Chee SP; Cunningham ET; Kestelyn P; Rathinam SR
    Int Ophthalmol Clin; 2010; 50(2):xv-xvi. PubMed ID: 20375858
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and management of noninfectious pediatric uveitis.
    Kim SJ
    Int Ophthalmol Clin; 2011; 51(1):129-45. PubMed ID: 21139481
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biological drugs in inflammatory bowel disease. Valuable supplement--but only when conventional therapy is not sufficient].
    Hellström PM; Schmidt D; Karlén P
    Lakartidningen; 2007 Oct 10-16; 104(41):2973-6. PubMed ID: 17977308
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapeutic approaches in ocular inflammatory diseases.
    Kurup SK; Chan CC
    Arch Immunol Ther Exp (Warsz); 2005; 53(6):484-96. PubMed ID: 16407781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.